PCN34 The Societal IMPACT of Obinutuzumab in the First-LINE Treatment of Follicular Lymphoma in China

Abstract

Authors

A. Launonen C. Bührer J. Wu C. Tsuchiya C. Liu X. Ran D. Dong L. Simonella H. Gu J. Ma

Full Text Cite This Article
Back to Volume 22, Supplemental S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×